Bridgeworth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$729K Sell
1,250
-12
-1% -$7K 0.07% 86
2023
Q3
$678K Hold
1,262
0.07% 87
2023
Q2
$592K Buy
1,262
+187
+17% +$78.4K 0.07% 94
2023
Q1
$369K Sell
1,075
-763
-42% -$257K 0.05% 112
2022
Q4
$672K Buy
1,838
+3
+0.2% +$1.06K 0.11% 87
2022
Q3
$593K Sell
1,835
-10
-0.5% -$3.17K 0.14% 82
2022
Q2
$598K Sell
1,845
-330
-15% -$99.1K 0.14% 81
2022
Q1
$623K Buy
2,175
+5
+0.2% +$1.29K 0.14% 74
2021
Q4
$599K Buy
2,170
+5
+0.2% +$1.27K 0.13% 75
2021
Q3
$500K Sell
2,165
-90
-4% -$22.2K 0.14% 77
2021
Q2
$518K Buy
2,255
+5
+0.2% +$1K 0.15% 73
2021
Q1
$420K Buy
2,250
+6
+0.3% +$1.17K 0.13% 77
2020
Q4
$379K Sell
2,244
-11
-0.5% -$1.64K 0.13% 78
2020
Q3
$334K Buy
2,255
+7
+0.3% +$1.08K 0.13% 83
2020
Q2
$369K Buy
2,248
+7
+0.3% +$1.07K 0.14% 84
2020
Q1
$311K Buy
2,241
+619
+38% +$85K 0.14% 88
2019
Q4
$213K Buy
+1,622
New +$188K 0.08% 123
2019
Q3
Sell
-2,524
Closed -$280K 136
2019
Q2
$280K Sell
2,524
-142
-5% -$16.7K 0.11% 91
2019
Q1
$346K Buy
2,666
+132
+5% +$16.1K 0.14% 83
2018
Q4
$205K Sell
2,534
-196
-7% -$21.9K 0.12% 114
2018
Q3
$212K Buy
2,730
+757
+38% +$75.7K 0.12% 115
2018
Q2
$168K Sell
1,973
-943
-32% -$77.5K 0.07% 155
2018
Q1
$224K Buy
+2,916
New +$235K 0.1% 133
2017
Q2
Sell
-3,167
Closed -$270K 148
2017
Q1
$270K Buy
+3,167
New +$254K 0.14% 113

Other funds holding LLY

Bridgeworth's LLY Position: Q4 2023 in Review

Bridgeworth reduced its Eli Lilly (LLY) stake by 0.95% in Q4 2023, selling an estimated $7K and leaving 1,250 shares worth $729K. The position accounts for 0.07% of the portfolio, ranked #86.

Bridgeworth first reported a position in LLY in Q1 2017 and has held it in 24 quarters since. 3,272 funds tracked by Wall St. Rank hold LLY as of Q4 2023.

  • Bridgeworth held 1,250 shares of Eli Lilly worth $729K as of Q4 2023.
  • Bridgeworth sold 12 Eli Lilly shares in Q4 2023, an estimated $7K.
  • Eli Lilly made up 0.07% of Bridgeworth's portfolio in Q4 2023, its #86 holding.
  • Bridgeworth first reported a position in Eli Lilly in Q1 2017 and has held it in 24 quarters since.
  • 3,272 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2023.

Based on Bridgeworth's 13F filing for Q4 2023, filed 26 Jan 2024.